Dianthus Therapeutics DNTH Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $1.36M.
The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dianthus Therapeutics's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dianthus Therapeutics's total debt?
- Dianthus Therapeutics (DNTH) reported total debt of $1.36M in Q1 2026.
- How has Dianthus Therapeutics's total debt changed year-over-year?
- Dianthus Therapeutics's total debt decreased by 2.3% year-over-year, from $1.4M to $1.36M.
- What is the long-term trend for Dianthus Therapeutics's total debt?
- Over 3 years (2022 to 2025), Dianthus Therapeutics's total debt has grown at a -64.1% compound annual growth rate (CAGR), from $29.96M to $1.39M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.